TEVA PHARMACEUTICAL INDUSTRIES LTD Human Resources Contracts & Agreements
50 Contracts & Agreements
- Bonus & Incentive Agreements (19 contracts)
- Compensation Agreements (1)
- Employment Agreements (28)
- Retirement Agreements (1)
- Separation Agreements (1)
- Employment Agreement, dated as of September 25, 2018, between Teva UK Limited and Richard Daniell (Filed With SEC on February 12, 2024)
- Employment Agreement, dated November 21, 2022, between Teva Pharmaceutical Industries Limited and Richard D. Francis (Filed With SEC on February 10, 2023)
- Amendment to Employment Agreement between Teva Pharmaceuticals USA, Inc. and Sven Dethlefs, dated as of July 18, 2018 (Filed With SEC on February 9, 2022)
- Employment Agreement, dated as of June 5, 2018, between Teva Pharmaceuticals USA, Inc. and Sven Dethlefs (Filed With SEC on February 9, 2022)
- Transfer Agreement of Employment Contract, dated as of March 20, 2020, between Teva Sante, Teva Pharmaceutical Industries Limited and Eric Drap (Filed With SEC on February 10, 2021)
- Employment Agreement, dated as of May 30, 2013, between Teva Sante and Eric Drap (Filed With SEC on February 10, 2021)
- Employment Agreement, dated as of March 12, 2020, between Teva Pharmaceutical Industries Limited and Eric Drap (Filed With SEC on February 10, 2021)
- Teva Pharmaceutical Industries Limited Israeli Subplan of Tevas 2020 Long-Term Equity-Based Incentive Plan (Filed With SEC on November 5, 2020)
- Form Award Agreement under Tevas 2020 Long-Term Equity-Based Incentive Plan (Filed With SEC on November 5, 2020)
- Amendment No. 1 dated as of June 9, 2020, to the Employment Agreement between Teva Pharmaceutical Industries Limited and Kre Schultz (Filed With SEC on June 9, 2020)
- Amendment to Employment Agreement between Teva Pharmaceutical Industries Limited and Eli Kalif, dated as of February 6, 2020 (Filed With SEC on February 21, 2020)
- Form Award Agreement (RSUs and PSUs) under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan (Filed With SEC on February 21, 2020)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2016 grants and 2017 grants made to... (Filed With SEC on February 21, 2020)
- Employment Agreement, dated as of November 6, 2019, between Teva Pharmaceutical Industries Limited and Eli Kalif (Filed With SEC on February 21, 2020)
- Employment Agreement, dated as of April 1, 2019, between Teva Pharmaceutical Industries Limited and Gianfranco Nazzi (Filed With SEC on February 21, 2020)
- Employment Agreement, dated as of December 22, 2013, between Teva Pharmaceuticals USA Inc. and Brendan OGrady (Filed With SEC on February 21, 2020)
- Separation Agreement, dated as of November 4, 2019, between Teva Pharmaceuticals USA, Inc. and Carlo de Notaristefani (Filed With SEC on February 21, 2020)
- Amendment to Employment Agreement between Teva Pharmaceuticals USA, Inc. and Hafrun Fridriksdottir, dated as of January 4, 2019 (Filed With SEC on February 19, 2019)
- Michael McClellan Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to September 18, 2017 grant (Filed With SEC on February 12, 2018)
- 2018 Form Bonus Letter Agreement (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2018 grants made to Kre Schultz, Michael... (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2010 Long-Term Equity-Based Incentive Plan applicable to selected 2015 grants made to Mark Sabag, Carlo de... (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2016 grants made to Mark Sabag, Carlo de... (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2017 grants made to Mark Sabag, Michael... (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2015 grants made to Michael McClellan (Filed With SEC on February 12, 2018)
- Hafrun Fridriksdottir Substitute Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to August 2, 2016... (Filed With SEC on February 12, 2018)
- Hafrun Fridriksdottir Substitute Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to August 2, 2016 stock... (Filed With SEC on February 12, 2018)
- Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2016 grants made to Michael McClellan and... (Filed With SEC on February 12, 2018)
- Carlo de Notaristefani Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to May 18, 2017 grant (Filed With SEC on February 12, 2018)
- Kre Schultz Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to November 3, 2017 grant (Filed With SEC on February 12, 2018)
- Hafrun Fridriksdottir Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2016 grants (Filed With SEC on February 12, 2018)
- Form Director Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2015, 2016 and 2017 grants (Filed With SEC on February 12, 2018)
- Teva Pharmaceuticals USA, Inc. Defined Contribution Supplemental Executive Retirement Plan (Filed With SEC on February 12, 2018)
- Teva Pharmaceuticals USA, Inc. Supplemental Deferred Compensation Plan (Filed With SEC on February 12, 2018)
- 2017 Form Bonus Letter Agreement, applicable to Rob Koremans, Dr. Michael Hayden, Hafrun Fridriksdottir, Carlo de Notaristefani, Eyal Desheh and Mark Sabag (Filed With SEC on February 12, 2018)
- Amended and Restated Employment Agreement, dated as of May 22, 2015, between Teva Pharmaceutical Industries Limited and Dr. Michael Hayden (Filed With SEC on February 12, 2018)
- Third Amendment to Employment Agreement between Teva Pharmaceuticals Europe B.V. and Rob Koremans, dated as of September 18, 2017 (Filed With SEC on February 12, 2018)
- Second Amendment to Employment Agreement between Teva Pharmaceuticals Europe B.V. and Rob Koremans, dated as of January 12, 2015 (Filed With SEC on February 12, 2018)
- First Amendment to Employment Agreement between Teva Pharmaceuticals Europe B.V. and Rob Koremans, dated as of October 30, 2012 (Filed With SEC on February 12, 2018)
- Employment Agreement, dated as of December 21, 2011, between Teva Pharmaceuticals Europe B.V. and Rob Koremans (Filed With SEC on February 12, 2018)
